Video (1:58)
CDC declares current flu season an "epidemic" - YouTube
Wednesday, December 31, 2014
Deutsche Wissenschaftler sicher: Fledermäuse haben Ebola übertragen - News Ausland - Bild.de
Das Rätsel um den bisher schwersten Ausbruch der Ebola-Seuche (mehr als 7500 Tote) ist offenbar gelöst.
Deutsche Wissenschaftler sicher: Fledermäuse haben Ebola übertragen - News Ausland - Bild.de
Deutsche Wissenschaftler sicher: Fledermäuse haben Ebola übertragen - News Ausland - Bild.de
Tuesday, December 30, 2014
Monday, December 29, 2014
Ebola czar: Mishandling of samples ‘unacceptable’ | TheHill
Ebola czar Ron Klain on Sunday defended the Centers for Disease Control’s response to the Ebola crisis, even as he criticized this week’s mishandling of a virus sample that exposed a technician to the disease.
Ebola czar: Mishandling of samples ‘unacceptable’ | TheHill
Ebola czar: Mishandling of samples ‘unacceptable’ | TheHill
Saturday, December 27, 2014
Wednesday, December 24, 2014
Virulent flu strain leaves hundreds sick, Tamiflu in great deman - KCTV5
KANSAS CITY, MO (KCTV) -
Read more: http://www.kctv5.com/story/27699115/virulent-flu-strain-leaves-hundreds-sick-tamiflu-in-great-demand#ixzz3Mo59ugTr
Virulent flu strain leaves hundreds sick, Tamiflu in great deman - KCTV5
Thousands of cases of influenza have been reported in Kansas and Missouri as the flu is raging across the country especially in the Midwest and South. A particularly virulent strain of influenza type A has sickened many, and the majority of flu shots weren't geared to cover the strain. Two-thirds of the flu cases being seen across the country weren't covered by the strains included in the flu shot.
Read more: http://www.kctv5.com/story/27699115/virulent-flu-strain-leaves-hundreds-sick-tamiflu-in-great-demand#ixzz3Mo59ugTr
Virulent flu strain leaves hundreds sick, Tamiflu in great deman - KCTV5
Tuesday, December 23, 2014
Kansas says new virus found after resident's death | Local News - KMBC Home
A new virus thought to be carried by ticks or other insects has been discovered following the death of a southeast Kansas resident during the summer, public health officials said Monday.
The new virus is called Bourbon virus, after Bourbon County, home of the patient who died. The Kansas Department of Health and Environment said the patient's symptoms, including fever and fatigue, were similar to symptoms from other tick-borne diseases.
Kansas says new virus found after resident's death | Local News - KMBC Home
The new virus is called Bourbon virus, after Bourbon County, home of the patient who died. The Kansas Department of Health and Environment said the patient's symptoms, including fever and fatigue, were similar to symptoms from other tick-borne diseases.
Kansas says new virus found after resident's death | Local News - KMBC Home
New International Wildlife Disease Training Course
From USDA:
Course participants practice swabbing wild ducks for diagnostic sampling
Protecting agriculture is nothing new for USDA’s Animal and Plant Health Inspection Service (APHIS), who is on the job 24/7 keeping livestock safe from animal disease. APHIS is sharing that expertise internationally to help countries protect livestock and threatened and endangered species from diseases like brucellosis, tuberculosis, avian influenza, bluetongue and rabies. APHIS, with help from the Foreign Agricultural Service (FAS), held a new training course specifically focused on wildlife disease issues. APHIS recently hosted wildlife disease specialists from all over the world, including Cambodia, Kenya, Mexico, Tanzania, Uganda, and Vietnam.
All of APHIS’ capacity building programs are designed to identify and reduce agricultural pest and disease threats while these threats are still outside of U.S. borders. Capacity building includes training and technology transfer to assist foreign partners in building their animal and plant health infrastructures. This capability, in turn, helps to reduce the chances that undetected agricultural threats will find pathways into the United States.
Dr. Charles Masembe, of Makerere University in Uganda, offered insights into feral swine surveillance activities in Uganda at the November training. “This course was a great opportunity to work with our counterparts at USDA and review materials on wildlife disease control. We’ll bring these materials back to our offices to share with our colleagues and promote safe practices in agricultural health and wildlife disease monitoring and research,” said Dr. Masembe.
Highlights of the wildlife disease course included a darting demonstration and an overview of avian trapping techniques. Lectures covered wildlife disease management issues and how wildlife diseases impact domestic livestock. Participants also conducted a disease outbreak simulation where they practiced diagnostic sampling techniques and biosafety and biosecurity protocols. The simulation used glow powder, which was only visible under black light to mimic pathogen exposure. At the end of the simulation instructors checked the participants with a black light to determine whether they were exposed to any of the glow powder while they practiced sampling techniques.
The course was held in Fort Collins, Colorado at APHIS’ National Wildlife Research Center and Colorado State University where participants worked side-by-side with U.S. subject matter experts on wildlife pests and diseases.
The Wildlife Disease Course is just one of many APHIS international capacity building activities. These activities promote science-based approaches to animal and plant health problems around the world. Capacity building training programs foster safe agricultural trade and help the US to maintain relationships with other countries and international organizations. Requests for APHIS expertise or technical assistance include topics such as veterinary epidemiology, regulatory processes and policy, wildlife control and surveillance, pest risk assessment, biotechnology, laboratory diagnostics, transboundary animal diseases, and other aspects of animal and plant health.
Monday, December 22, 2014
Ahead of Print -Influenza A(H10N7) Virus in Dead Harbor Seals, Denmark - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC
Friday, December 19, 2014
Ahead of Print -Regional Spread of Ebola Virus, West Africa, 2014 - Volume 21, Number 3—March 2015 - Emerging Infectious Disease journal - CDC
Thursday, December 18, 2014
Ahead of Print -Delicacy and Durability: The Microbiological Sublime - Volume 21, Number 1—January 2015 - Emerging Infectious Disease journal - CDC
Bird Flu Detected
From the U.S. Geological Survey (USGS):
Avian flu, or "bird flu," is in #Washington state. There is no public health concern at this time.
Following a recent wild bird die-off at Wiser Lake, the#USGS identified highly pathogenic avian flu in samples from Whatcom County, Washington. Two strains of the virus are now confirmed: H5N2 in northern pintail ducks and H5N8 in captive gyrfalcons that were fed hunter-killed wild birds. Neither virus has been found in U.S. commercial poultry.
Read about the current situation athttp://on.doi.gov/13gk0Uw. General information about avian influenza is available at http://on.doi.gov/1iTCjQf.
Photo: A male northern pintail duck. (Credit: USGS)
Avian flu, or "bird flu," is in #Washington state. There is no public health concern at this time.
Following a recent wild bird die-off at Wiser Lake, the#USGS identified highly pathogenic avian flu in samples from Whatcom County, Washington. Two strains of the virus are now confirmed: H5N2 in northern pintail ducks and H5N8 in captive gyrfalcons that were fed hunter-killed wild birds. Neither virus has been found in U.S. commercial poultry.
Read about the current situation athttp://on.doi.gov/13gk0Uw. General information about avian influenza is available at http://on.doi.gov/1iTCjQf.
Photo: A male northern pintail duck. (Credit: USGS)
Monday, December 15, 2014
Saturday, December 13, 2014
Thursday, December 11, 2014
Wednesday, December 10, 2014
Ahead of Print -Endophthalmitis Outbreak Associated with Repackaged Bevacizumab - Volume 21, Number 1—January 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Fatal Legionellosis after Water Birth, Texas, USA, 2014 - Volume 21, Number 1—January 2015 - Emerging Infectious Disease journal - CDC
Monday, December 8, 2014
Infectious Disease Expert Jeremy Farrar on Ebola Epidemic - SPIEGEL ONLINE
British medical expert Jeremy Farrar is a key figure in the fight against Ebola and other infectious diseases. In a SPIEGEL interview, he says that the development of vaccines is key because drug-resistant viruses and bacteria pose immense dangers.
Infectious Disease Expert Jeremy Farrar on Ebola Epidemic - SPIEGEL ONLINE
Infectious Disease Expert Jeremy Farrar on Ebola Epidemic - SPIEGEL ONLINE
Saturday, December 6, 2014
IBM News room - 2014-12-03 Volunteers Can Now Help Scripps Research Institute Scientists Seek Ebola Cure in Their (Computers') Spare Time - United States
IBM's SoftLayer cloud-enabled World Community Grid to provide free virtual supercomputer power to The Scripps Research Institute to speed screening of promising chemical compounds
IBM News room - 2014-12-03 Volunteers Can Now Help Scripps Research Institute Scientists Seek Ebola Cure in Their (Computers') Spare Time - United States
IBM News room - 2014-12-03 Volunteers Can Now Help Scripps Research Institute Scientists Seek Ebola Cure in Their (Computers') Spare Time - United States
Thursday, December 4, 2014
Ahead of Print -Pneumonic Plague Outbreak, Northern Madagascar, 2011 - Volume 21, Number 1—January 2015 - Emerging Infectious Disease journal - CDC
Wednesday, December 3, 2014
Friday, November 28, 2014
Ebola Vaccine Search Moves Ahead Rapidly - SPIEGEL ONLINE
Medical researchers are frantically testing new drugs and vaccines in the hope of slowing down the Ebola epidemic. Thus far, results have been promising. It may only be a matter of weeks before the first patients in West Africa can be treated.
Ebola Vaccine Search Moves Ahead Rapidly - SPIEGEL ONLINE
Ebola Vaccine Search Moves Ahead Rapidly - SPIEGEL ONLINE
Wednesday, November 26, 2014
Ahead of Print -Post-Chikungunya Rheumatoid Arthritis, Saint Martin - Volume 21, Number 3—March 2015 - Emerging Infectious Disease journal - CDC
Tuesday, November 25, 2014
Monday, November 17, 2014
Friday, November 14, 2014
Wednesday, November 12, 2014
Ahead of Print -Human Metapneumovirus Infection in Chimpanzees, United States - Volume 20, Number 12—December 2014 - Emerging Infectious Disease journal - CDC
Ahead of Print -Zoonotic Baylisascaris procyonis Roundworms in Raccoons, China - Volume 20, Number 12—December 2014 - Emerging Infectious Disease journal - CDC
Tuesday, November 11, 2014
Wednesday, November 5, 2014
Friday, October 31, 2014
Wednesday, October 22, 2014
Beating Ebola: One Company's Fight in Liberia Shows How to Do It - NBC News.com
Long before anyone suspected Ebola would cause the raging epidemic that’s killing thousands of people every month in West Africa, a woman got sick on a huge rubber tree plantation in Liberia.
What Firestone Liberia Inc. did in response to that March case is a textbook example of how to fight the virus, public health experts say.
Beating Ebola: One Company's Fight in Liberia Shows How to Do It - NBC News.com
Monday, October 20, 2014
EEUU refuerza sus protocolos contra el ébola - Univision Noticias
Se prevé la implementación de un equipo de protección “que no deje expuesta la piel” para mediar el contacto.
EEUU refuerza sus protocolos contra el ébola - Univision Noticias
EEUU refuerza sus protocolos contra el ébola - Univision Noticias
Containing Ebola Outbreak
Interview with Richard Preston
Richard Preston, "Demon in the Freezer" author, says there is hope scientist will be able to find a vaccine to battle the deadly Ebola virus but for now it is out of control in West Africa.
http://video.cnbc.com/gallery/?video=3000321525
Richard Preston, "Demon in the Freezer" author, says there is hope scientist will be able to find a vaccine to battle the deadly Ebola virus but for now it is out of control in West Africa.
http://video.cnbc.com/gallery/?video=3000321525
Friday, October 17, 2014
Wednesday, October 15, 2014
Official: If we knew, we would have sent Duncan to Emory - YouTube
Video (2:40)
A second health care worker in Texas who cared for Thomas Eric Duncan has tested positive for Ebola, officials say.
Official: If we knew, we would have sent Duncan to Emory - YouTube
A second health care worker in Texas who cared for Thomas Eric Duncan has tested positive for Ebola, officials say.
Official: If we knew, we would have sent Duncan to Emory - YouTube
Tuesday, October 14, 2014
'Surge' of Ebola personnel sent to Dallas | TheHill
A “surge” of personnel and other resources has been sent to Dallas to help discover how a nurse was infected with Ebola, top health officials told President Obama during an Oval Office meeting on Monday.
The president stressed that the investigation into the second U.S. infection “should proceed as expeditiously as possible and that lessons learned should be integrated into future response plans and disseminated to hospitals and healthcare workers nationwide.” He said officials should move “as expeditiously as possible,” according to the White House.
'Surge' of Ebola personnel sent to Dallas | TheHill
The president stressed that the investigation into the second U.S. infection “should proceed as expeditiously as possible and that lessons learned should be integrated into future response plans and disseminated to hospitals and healthcare workers nationwide.” He said officials should move “as expeditiously as possible,” according to the White House.
'Surge' of Ebola personnel sent to Dallas | TheHill
Feds rethinking Ebola strategy | TheHill
The Centers for Disease Control and Prevention (CDC) on Monday said it is starting to “rethink” its Ebola strategy after the first-ever US transmission of the virus put a "relatively large" number of healthcare workers at risk.
Feds rethinking Ebola strategy | TheHill
Feds rethinking Ebola strategy | TheHill
Monday, October 13, 2014
Hospital officials: Kansas City patient at risk for Ebola - KCTV5
KANSAS CITY, KS (KCTV) -
Read more: http://www.kctv5.com/story/26775426/hospital-officials-kansas-city-patient-at-risk-for-ebola#ixzz3G4OjTbzn
Hospital officials: Kansas City patient at risk for Ebola - KCTV5
Hospital officials in Kansas City say a patient at risk for Ebola is in strict isolation.
Read more: http://www.kctv5.com/story/26775426/hospital-officials-kansas-city-patient-at-risk-for-ebola#ixzz3G4OjTbzn
Hospital officials: Kansas City patient at risk for Ebola - KCTV5
McCaul eyes suspension of visas from West Africa | TheHill
Rep. Michael McCaul (R-Texas) said on Sunday that officials should consider suspending visas from West African nations at the center of the Ebola outbreak
McCaul eyes suspension of visas from West Africa | TheHill
McCaul eyes suspension of visas from West Africa | TheHill
McCain calls for Ebola 'czar' | TheHill
Sen. John McCain (R-Ariz.) on Sunday called for President Obama to nominate an Ebola "czar" to coordinate the administration’s response to the deadly virus.
“I’d like to know who’s in charge,” McCain said on CNN’s “State of the Union.”
McCain calls for Ebola 'czar' | TheHill
CDC director: More Ebola cases possible | TheHill
The director of the Centers for Disease Control and Prevention (CDC) on Sunday said more Ebola cases are possible after a healthcare worker at a Dallas hospital tested positive for the deadly virus.
CDC director: More Ebola cases possible | TheHill
CDC director: More Ebola cases possible | TheHill
Sunday, October 12, 2014
'Close to home': Neighbors of Dallas Ebola patient concerned
Many residents of a Dallas neighborhood were woken early Sunday morning by a knock on their doors from city officials handing out Ebola information pamphlets and informing them that someone who lives nearby had tested positive for Ebola. "It's one thing to be in Dallas but for it to be next door, it's like really close to home," the unidentified patient's next door neighbor, Chelsea Esposito, told NBC Dallas-Fort Worth. Texas Health Presbyterian Hospital announced Sunday morning that a health care worker who treated Ebola victim Thomas Eric Duncan had tested positive for the disease. Duncan died Wednesday. The Centers for Disease Control in Atlanta confirmed the health care worker tested positive for Ebola — the first known case of the virus being transmitted in the U.S.
'Close to home': Neighbors of Dallas Ebola patient concerned
'Close to home': Neighbors of Dallas Ebola patient concerned
Saturday, October 4, 2014
Two children treated for paralysis, possible enterovirus-68 in M - KCTV5
ST. LOUIS, MO (KMOV/CNN) - Doctors at St. Louis Children's Hospital are seeing children with muscle weakness or even paralysis, which is possibly related to the rare enterovirus-68.
Two children are being treated in St. Louis for a severe symptom - muscle weakness or paralysis that could be linked to EV-68.
Read more: http://www.kctv5.com/story/26704449/two-children-treated-for-paralysis-possible-enterovirus-68-in-mo#ixzz3FCp8A8kP
Two children treated for paralysis, possible enterovirus-68 in M - KCTV5
Friday, October 3, 2014
Health officials clam up about effort to contain Ebola in Texas | TheHill
Health officials are refusing to answer growing questions about their response to the first Ebola case in the United States.
Under intense questioning from reporters, officials with the Centers for Disease Control and Prevention (CDC), the Texas health department and the City of Dallas repeatedly declined Thursday to provide details about the steps being taken to prevent an outbreak.
Health officials clam up about effort to contain Ebola in Texas | TheHill
NBC freelancer contracts Ebola in Liberia | TheHill
An American freelance cameraman working with an NBC News crew in Liberia tested positive for Ebola on Thursday and will be flown back to the United States for treatment.
NBC News President Deborah Turness said four other NBC News employees, including Chief Medical Editor Nancy Snyderman, will be flown back the United States on a private charter plane and quarantined for 21 days out of an abundance of caution.
NBC freelancer contracts Ebola in Liberia | TheHill
¿Cómo sé que es gripe y no Ébola?
The scene that showed Thomas Eric Duncan, the Ebola patient being treated at Texas Health Presbyterian Hospital in Dallas, was a surprise to doctors, who mistook the symptoms for a common infection and prescribed antibiotics. What signs does Ebola present at the beginning and how to clear the doubts?
¿Cómo sé que es gripe y no Ébola?
¿Cómo sé que es gripe y no Ébola?
Thursday, October 2, 2014
80 people in contact with Dallas Ebola patient, family: NBC
NBC has confirmed with the Dallas county health and human services that 80 people came into contact with the Dallas Ebola patient or his family.
Director Zachary Thompson said these 80 people were not in close contact, but they did have some kind of contact with or exposure to the patient.
80 people in contact with Dallas Ebola patient, family: NBC
Wednesday, October 1, 2014
Tuesday, September 30, 2014
First-Ever Case of Ebola Diagnosed in U.S. | TheBlaze.com
A patient in Dallas has tested positive for the Ebola virus, the first time the virus has been diagnosed inside the United States.
A report from Fox News said the Dallas County Health Department said the patient was recently in Africa, where the virus has claimed the lives of thousands in an epidemic that has spread across country borders.
First-Ever Case of Ebola Diagnosed in U.S. | TheBlaze.com
Saturday, September 27, 2014
Monday, September 22, 2014
Ahead of Print -Novel Bluetongue Virus in Goats, Corsica, France, 2014 - Volume 20, Number 12—December 2014 - Emerging Infectious Disease journal - CDC
Sunday, September 21, 2014
Gilead Announces Generic Licensing Agreements to Increase Access to Hepatitis C Treatments in Developing Countries
News Release:
NEW DELHI --(BUSINESS WIRE)--Sep. 15, 2014-- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has signed non-exclusive licensing agreements with seven India -based generic pharmaceutical manufacturers to expand access to its chronic hepatitis C medicines in developing countries. The agreements allow the companies – Cadila Healthcare Ltd. , Cipla Ltd. , Hetero Labs Ltd. , Mylan Laboratories Ltd. , Ranbaxy Laboratories Ltd. , Sequent Scientific Ltd. and Strides Arcolab Ltd. – to manufacture sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir for distribution in 91 developing countries.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California , Gilead has operations in North and South America , Europe and Asia Pacific .
Gilead Announces Generic Licensing Agreements to Increase Access to Hepatitis C Treatments in Developing Countries
-- Indian companies granted license to produce generic sofosbuvir and investigational single tablet regimen of ledipasvir/sofosbuvir for treatment of chronic hepatitis C --
The countries within the agreement account for more than 100 million people living with hepatitis C, representing 54% of the total global infected population.
“Hepatitis C is a significant public health issue worldwide, and Gilead is working to make its chronic hepatitis C medicines accessible to as many patients, in as many places, as quickly as possible. In developing countries, large-volume generic manufacturing and distribution is widely regarded as a key component in expanding access to medicines. These agreements are essential to advancing the goals of our humanitarian program in these countries,” commented Gregg H. Alton , Executive Vice President, Corporate and Medical Affairs, Gilead Sciences .
Under the licensing agreements, the Indian companies receive a complete technology transfer of the Gilead manufacturing process to enable them to scale up production as quickly as possible. The licensees also set their own prices for the generic product they produce, paying a royalty on sales to Gilead to support product registrations, medical education and training, safety monitoring and other essential business activities. The licenses also permit the manufacture of sofosbuvir or ledipasvir in combination with other chronic hepatitis C medicines.
Sofosbuvir was approved under the trade name Sovaldi® by the U.S. Food and Drug Administration (FDA ) in December 2013 and by the European Commission in January 2014 . The FDA and the European Medicines Agency are currently reviewing the company’s applications for a single tablet regimen of ledipasvir/sofosbuvir; it is an investigational agent and its safety and efficacy have not been established.
For a fact sheet on the agreement, visit www.gilead.com.
Gilead’s Approach to Treatment Access in Developing Countries
Gilead makes it a priority to increase access to its medicines for people who can benefit from them, regardless of where they live or their economic means. In developing countries, Gilead’s treatment access strategies include tiered pricing, voluntary generic licensing (often in advance of U.S./EU regulatory approval), negotiation with national governments, regional business partnerships, product registration, medical education and partnerships with non-profit organizations. This approach has been successfully applied to Gilead’s humanitarian program in HIV over the past ten years, with six million patients now receiving Gilead-based HIV medicines in developing countries.
About Gilead Sciences
Forward-Looking Statement
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the possibility that licensees will not be able to produce and distribute generic versions of Gilead medicines, that licensing terms will be modified or that ledipasvir/sofosbuvir does not receive regulatory approval. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 , as filed with the U.S. Securities and Exchange Commission . All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.
U.S. full prescribing information for Sovaldi is available at www.gilead.com.
Sovaldi is a registered trademark of Gilead Sciences, Inc.
For more information on Gilead Sciences , please visit the company’s website at www.Gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140915005379/en/
Source: Gilead Sciences, Inc.
Saturday, September 20, 2014
The fight against Ebola is grossly underfunded - Sep. 20, 2014
The Ebola virus has already killed thousands in West Africa, an immeasurable loss for many families. As medical workers try to quell its spread, global organizations are calculating the economic impact of the disease.
"Their economies are basically being devastated," said Daniel Epstein, a spokesperson for the World Health Organization. "Economic activity has halted in many areas there. The harvest isn't going on. People can't fly in and fly out."
The fight against Ebola is grossly underfunded - Sep. 20, 2014
Friday, September 19, 2014
Thursday, September 18, 2014
Wednesday, September 17, 2014
¿Por qué militares y no médicos contra Ébola?
El presidente Barack Obama anunciará en forma oficial un amplio programa de recursos militares para luchar en Liberia contra la propagación del mortal virus, según funcionarios de la administración del gobierno. ¿En qué consiste el plan?
¿Por qué militares y no médicos contra Ébola?
¿Por qué militares y no médicos contra Ébola?
Monday, September 15, 2014
Sunday, September 14, 2014
Saturday, September 13, 2014
Tuesday, September 9, 2014
German Doctor Shares Story of Ebola Encounter in Sierra Leone - SPIEGEL ONLINE
After the discovery of Ebola at the only children's hospital in Sierra Leone, nurses and doctors alike fled. German physician Werner Strahl of the aid organzation Cap Anamur, who stayed behind to provide care amidst the chaos, shares his story.
German Doctor Shares Story of Ebola Encounter in Sierra Leone - SPIEGEL ONLINE
German Doctor Shares Story of Ebola Encounter in Sierra Leone - SPIEGEL ONLINE
New respiratory virus hits Kansas City area kids | The Kansas City Star
A respiratory virus new to the Kansas City area has Children’s Mercy Hospital mobilizing the way it does during the peak of the winter cold and flu season.
“Usually August is our low season for respiratory virus,” Mary Anne Jackson, chief of the infectious diseases section at Children’s Mercy, said Friday.
New respiratory virus hits Kansas City area kids | The Kansas City Star
Monday, September 8, 2014
How the Ebola Outbreak in Africa Could Become a Threat to Europe - SPIEGEL ONLINE
With Ebola spreading rapidly in Nigeria and other parts of West Africa, international organizations fear the number of infections could exceed 20,000. Experts are calling for the industrialized world to do more to help stop the virus.
How the Ebola Outbreak in Africa Could Become a Threat to Europe - SPIEGEL ONLINE
How the Ebola Outbreak in Africa Could Become a Threat to Europe - SPIEGEL ONLINE
Sunday, September 7, 2014
Possible enterovirus outbreak sickens more than 900 children - KCTV5
DENVER (KMGH/CNN) - Hospitals across the metro area are on alert for a mystery respiratory illness that can leave children and teenagers with asthma debilitated.
Possible enterovirus outbreak sickens more than 900 children - KCTV5
Possible enterovirus outbreak sickens more than 900 children - KCTV5
Saturday, September 6, 2014
Friday, September 5, 2014
Ahead of Print -Chikungunya Virus Imported into French Polynesia, 2014 - Volume 20, Number 10—October 2014 - Emerging Infectious Disease journal - CDC
Ahead of Print -Two Human Cases of Rickettsia felis Infection, Thailand - Volume 20, Number 10—October 2014 - Emerging Infectious Disease journal - CDC
Ahead of Print -Probable Importation of Dengue Virus Type 4 to Angola from Brazil - Volume 20, Number 10—October 2014 - Emerging Infectious Disease journal - CDC
Wednesday, September 3, 2014
Ahead of Print -Pulmonary Disease Caused by Mycobacterium marseillense, Italy - Volume 20, Number 10—October 2014 - Emerging Infectious Disease journal - CDC
Monday, September 1, 2014
Wednesday, August 27, 2014
WHO shuts Sierra Leone lab after worker infected with Ebola | Reuters
(Reuters) - The World Health Organization (WHO) said on Tuesday it had shut a laboratory in Sierra Leone after a health worker there was infected with Ebola, a move that may hamper efforts to boost the global response to the worst ever outbreak of the disease.
At least 1,427 people have died and 2,615 have been infected since the disease was detected deep in the forests of southeastern Guinea in March.
WHO shuts Sierra Leone lab after worker infected with Ebola | Reuters
Ebola-infizierter WHO-Mitarbeiter zur Behandlung in Deutschland eingetroffen | Aktuell Deutschland | DW.DE | 27.08.2014
Es gilt die höchste Sicherheitsstufe. Spezialjet und Isolier-Rettungswagen sind im Einsatz, als in Hamburg der erste Ebola-Patient aus Westafrika eintrifft.
Ebola-infizierter WHO-Mitarbeiter zur Behandlung in Deutschland eingetroffen | Aktuell Deutschland | DW.DE | 27.08.2014
Ebola-infizierter WHO-Mitarbeiter zur Behandlung in Deutschland eingetroffen | Aktuell Deutschland | DW.DE | 27.08.2014
Thursday, August 21, 2014
Wednesday, August 20, 2014
Tuesday, August 19, 2014
Sunday, August 17, 2014
Mob Destroys Ebola Center In Liberia Two Days After It Opens
MONROVIA, Liberia — This morning Makasha Kroma shivered with fever. Her head still hurt; that hadn’t gone away. And she was vomiting a lot.
That’s why she’d ended up here, at a holding center where people suspected to have Ebola wait, in a dark classroom, for the results of their tests. These things — headache, fever, vomiting — are the early signs.
Mob Destroys Ebola Center In Liberia Two Days After It Opens
That’s why she’d ended up here, at a holding center where people suspected to have Ebola wait, in a dark classroom, for the results of their tests. These things — headache, fever, vomiting — are the early signs.
Mob Destroys Ebola Center In Liberia Two Days After It Opens
Friday, August 15, 2014
Wednesday, August 13, 2014
Tuesday, August 12, 2014
Monday, August 11, 2014
Ebola infections top 1,800 | TheHill
A top World Health Organization (WHO) official on Sunday said the number of patients infected by the Ebola virus has risen to 1,825 in four African countries.
Dr. Keiji Fukuda, the assistant director general of health security for the World Health Organization, said on CBS’s “Face the Nation” that approximately 900 people have died in the outbreak, and that number is expected to increase.
Read more: http://thehill.com/policy/healthcare/214788-ebola-infections-top-1800#ixzz3A5LOYt00
Follow us: @thehill on Twitter | TheHill on Facebook
Ebola infections top 1,800 | TheHill
Sunday, August 10, 2014
Ebola in Westafrika: Flughunde als Reservoir des Erregers - International Nachrichten - NZZ.ch
We know the pathways and the reservoir of the Ebola virus. Why is this outbreak not contained?
Ebola in Westafrika: Flughunde als Reservoir des Erregers - International Nachrichten - NZZ.ch
Ebola in Westafrika: Flughunde als Reservoir des Erregers - International Nachrichten - NZZ.ch
Saturday, August 9, 2014
FDA allows limited use of Ebola drug. Tekmira stock spikes 45% - Aug. 8, 2014
The company behind a potential Ebola drug is red-hot again.
Canadian biotech firm Tekmira Pharmaceuticals (TKMR)announced that the Federal Drug Administration knocked down a key barrier to its medicine, TKM Ebola, reaching some patients. The FDA moved the drug from a "full hold" to a "partial hold," which means Tekmira can use the drug in limited experiments.
FDA allows limited use of Ebola drug. Tekmira stock spikes 45% - Aug. 8, 2014
Monday, August 4, 2014
Time to act on the 'other' health crisis – Global Public Square - CNN.com Blogs
It’s not surprising that international attention has been focused on the ongoing outbreak of Ebola that has struck West Africa. After all, there are few treatment options for the disease, which has a case fatality rate of up to 90 percent, and the current outbreak has been described as the deadliest outbreak in history. Indeed, Britain’s government recently held an emergency meeting to discuss the possible threat to the country, although the foreign secretary said he believes Britain has the expertise to deal with the threat.
But while Ebola is getting the headlines, another health threat has been growing across the globe, one with implications every bit as serious: the rapid rise of antibiotic resistant bacteria.
Time to act on the 'other' health crisis – Global Public Square - CNN.com Blogs
Sunday, August 3, 2014
Saturday, August 2, 2014
STDs are on the rise in Miami-Dade - Miami-Dade - MiamiHerald.com
Rates of both chlamydia and syphilis in Miami-Dade have nearly doubled since 2006, according to new statistics from the Florida Department of Health.
The rise in sexually transmitted diseases is an unsettling and largely unnoticed trend, said Alex Moreno, the clinical program manager for the adolescent medicine division at the University of Miami Miller School of Medicine.
STDs are on the rise in Miami-Dade - Miami-Dade - MiamiHerald.com
Friday, August 1, 2014
Thursday, July 31, 2014
Ebola-Notstand in Westafrika | Aktuell Afrika | DW.DE | 31.07.2014
Angesichts der in Westafrika wütenden Ebola-Epidemie haben Liberia und Sierra Leone den Gesundheits-Notstand ausgerufen. Beide Länder kündigen verschärfte Maßnahmen gegen die Seuche an.
Ebola-Notstand in Westafrika | Aktuell Afrika | DW.DE | 31.07.2014
Ebola-Notstand in Westafrika | Aktuell Afrika | DW.DE | 31.07.2014
Wednesday, July 30, 2014
Novartis vaccine Bexsero® sees high uptake in first large-scale public vaccination program to help protect against devastating meningitis B
Basel, July 29, 2014 - Novartis has announced the initial results of a large-scale vaccination campaign with Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) to help protect against meningitis B within the Saguenay-Lac-Saint-Jean region of Québec, Canada. This public program adds to the growing real-world experience of Bexsero, which is approved in 34 countries, including the European Union, Australia and Canada[3],[4],[5],[6].
This regional program is the first of its kind globally and has reached 81% of the campaign's target population within the first three months[2]. This encompasses more than 45,000 infants, young children and adolescents from 2 months to 20 years of age[2]. The high rate of uptake in this public vaccination program with Bexsero demonstrates the value placed on preventing meningitis B within communities that are afforded access.
Novartis vaccine Bexsero® sees high uptake in first large-scale public vaccination program to help protect against devastating meningitis B
Alerta por brotes del virus Chikungunya en EE UU
Surgen nuevos casos en EEUU del virus causado por la picadura de mosquito que produce fuertes dolores y debilidad.
Tuesday, July 29, 2014
Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen’s Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C | Johnson & Johnson
CORK, Ireland (July 28, 2014) -- Results from the Phase 2 COSMOS (Combination Of SiMeprevir and sOfosbuvir in HCV genotype 1 infected patientS) clinical study were published July 28 in The Lancet, demonstrating that 92 percent of genotype 1 chronic hepatitis C virus (HCV) adult patients treated with Janssen R&D Ireland’s (Janssen) simeprevir, an NS3/4A protease inhibitor, in combination with sofosbuvir, achieved sustained virologic response 12 weeks after the end of treatment (SVR12), including those patients with compensated cirrhosis and prior null response to treatment with pegylated interferon (PegIFN) and ribavirin (RBV).
According to findings from the study, the all-oral 12-week, interferon-free treatment regimen with simeprevir and sofosbuvir resulted in consistent SVR12 rates regardless of degree of fibrosis, and was an effective and well-tolerated therapeutic regimen in both treatment-naïve and prior null-responder patients.
Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen’s Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C | Johnson & Johnson
Monday, July 28, 2014
Doctor who trained in Ft. Worth contracts Ebola - Dallas News | myFOXdfw.com
A doctor who trained in Fort Worth is asking for prayers after contracting the Ebola virus in Africa.
Dr. Kent Brantly, 33, is part of a medical aid group fighting an Ebola outbreak in West Africa.
Doctor who trained in Ft. Worth contracts Ebola - Dallas News | myFOXdfw.com
Dr. Kent Brantly, 33, is part of a medical aid group fighting an Ebola outbreak in West Africa.
Doctor who trained in Ft. Worth contracts Ebola - Dallas News | myFOXdfw.com
Subscribe to:
Comments (Atom)